SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$0.25
-0.01 (-4.57%)
Open$0.26
Previous Close$0.26
Day High$0.28
Day Low$0.24
52W High$42.60
52W Low—
Volume—
Avg Volume14.26M
Market Cap1.50M
P/E Ratio—
EPS$-56.45
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+14,489.4% upside
Current
$0.25
$0.25
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.24M | 2.11M | 2.20M |
| Net Income | -331,103 | -245,653 | -236,110 |
| Profit Margin | -14.8% | -11.6% | -10.7% |
| EBITDA | -455,957 | -486,512 | -478,296 |
| Free Cash Flow | -187,144 | -193,211 | -204,399 |
| Rev Growth | -3.1% | +9.8% | -1.4% |
| Debt/Equity | 0.51 | 0.41 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |